[Federal Register Volume 70, Number 65 (Wednesday, April 6, 2005)]
[Notices]
[Pages 17472-17473]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-6786]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in Schedule I or II and prior to issuing a 
registration under 21 U.S.C. 952 (a) (2) (B) authorizing the 
importation of such a substance, provide manufacturers holding 
registrations for the bulk manufacture of the substance an opportunity 
for a hearing.
    Therefore, in accordance with 21 CFR 1301.34(a), this is notice 
that on February 1, 2005, Penick Corporation, 158 Mount Olivet Avenue, 
Newark, New Jersey 07114, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as an importer of the 
basic classes of controlled substances listed in Schedules II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Coca Leaves (9040).........................  II
Raw Opium (9600)...........................  II
Poppy Straw (9650).........................  II
Poppy Straw Concentrate (9670).............  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances to 
manufacturer bulk controlled substances and non-controlled substance 
flavor extracts.
    Any manufacturer who is presently, or is applying to be, registered 
with DEA

[[Page 17473]]

to manufacture such basic classes of controlled substances may file 
comments or objections to the issuance of the proposed registration and 
may, at the same time, file a written request for a hearing on such 
application pursuant to 21 CFR 1301.43 and in such form as prescribed 
by 21 CFR 1316.47.
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than May 6, 2005.
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1301.34(b), (c), (d), 
(e) and (f). As noted in a previous notice published in the Federal 
Register on September 23, 1975, (40 FR 43745-46), all applicants for 
registration to import a basic class of any controlled substance listed 
in Schedule I or II are, and will continue to be required to 
demonstrate to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, that the requirements for 
such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 
21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied.

    Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-6786 Filed 4-5-05; 8:45 am]
BILLING CODE 4410-09-P